Evidence map›Paper›PMID 40894664›Full record

ArticlebioRxiv : the preprint server for biology2025

Single-Cell Characterization of Anterior Segment Development: Cell Types, Pathways, and Signals Driving Formation of the Trabecular Meshwork and Schlemm's Canal.

Revathi Balasubramanian, Nicholas Tolman, Taibo Li, Abdul Hannan, Violet Bupp-Chickering, Karina Polanco, Aakriti Bhandari, Sally Zhou, Marina Simón, John Peregrin and 4 more

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Revathi BalasubramanianDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-2209-0815
Nicholas TolmanDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Taibo LiDepartment of Molecular Biology and Genetics, Johns Hopkins University, Baltimore, MD.
Abdul HannanDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Violet Bupp-ChickeringDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Karina PolancoDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Aakriti BhandariDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Sally ZhouDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Marina SimónDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
John PeregrinDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Christa MontgomeryDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.
Krishnakumar KizhatilDepartment of Ophthalmology and Visual Sciences, College of Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
Jiang QianDepartment of Ophthalmology, Johns Hopkins School of Medicine, Baltimore, MD.
Simon W M JohnDepartment of Ophthalmology, Columbia University Irving Medical Center, New York, NY.ORCID 0000-0002-4319-0356

Funding

Instrumentation, Fabrication, and Design CoreP30EY019007 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Xin Zhang · 2010 to 2026
$12.9M
Factors Determining Intraocular Pressure and Glaucoma SusceptibilityR01EY011721 · NEI · JACKSON LABORATORY · PI JOHN, SIMON W · 2002 to 2018
$12.4M
Cell Death Pathways in Glaucomatous NeurodegenerationR01EY018606 · NEI · UNIVERSITY OF ROCHESTER · PI JOHN, SIMON W, LIBBY, RICHARD T · 2008 to 2023
$5.8M
Does VECAD at Schlemm canal cell-junctions determine IOP and glaucoma risk?R01EY032062 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JOHN, SIMON W, KIZHATIL, KRISHNAKUMAR · 2021 to 2025
$3.5M
Models, mechanisms and treatment of LMX1B-induced glaucomaR01EY032507 · NEI · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI JOHN, SIMON W · 2021 to 2024
$2.3M
Elucidating and bypassing molecular mechanisms that suppress Muller glia-dependent regeneration of cones in two zebrafish models of chronic retinal damageR01EY034493 · NEI · UNIVERSITY OF NOTRE DAME · PI Seth Blackshaw, David R Hyde · 2023 to 2026
$2.3M
NEI NIH HHS P30 EY019007NEI NIH HHS R01 EY011721NEI NIH HHS R01 EY018606NEI NIH HHS R01 EY032062NEI NIH HHS R01 EY032507NEI NIH HHS R01 EY034493
6 · The paper itself

Abstract

Morphogenesis of the anterior segment (AS) is crucial for healthy ocular physiology and vision but is only partially understood. The Schlemm's canal (SC) and trabecular meshwork (TM) are essential drainage tissues within the AS, and their proper development and function are critical for maintaining normal intraocular pressure; abnormalities in either tissue can result in elevated pressure and glaucoma. Here, we use single-cell transcriptomic profiling to provide high-resolution molecular detail of AS development with a particular focus on SC and TM. We report transcriptomes for ~130,000 single cells at key developmental stages from postnatal day 2 (P2) to P60. We provide the first annotation of cell types across these developmental stages and crucial information about dynamic changes in pathways/gene expression. Further, we trace developmental trajectories for TM cell and SC endothelial cell (SEC) subtypes and determine genes and signaling networks driving their specific cell fates. We demonstrate dynamic changes in signaling interactions between SC and the TM cells during their synchronized development. Collectively, our data lay a deep molecular foundation for AS development that will direct understanding of normal ocular physiology, glaucoma, and other AS conditions.

Identifiers

PMID40894664
PMCPMC12393362

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.